Search - tctmd.com

Displaying 161 - 180 of 208

Sort: Relevancy | Date

News Daily News

Transradial PCI May Attenuate Bivalirudin Benefits

Todd Neale

October 05, 2015

News Daily News

BASKET-PROVE Substudy: DES Better Than BMS in Elderly Patients With Large Arteries

Yael L. Maxwell

July 29, 2015

News Industry News

Navidea and Massachusetts General Hospital to Evaluate Manocept™ for Detection of Cardiovascular Disease with NIH Grant

July 28, 2015

News Daily News

肺栓塞发作后，二级抗凝效果未持续

L.A. McKeown

July 13, 2015

News Daily News

Después de Sufrir un Embolismo Pulmonar el Beneficio de la Anticoagulación Secundaria No se Mantiene

L.A. McKeown

July 13, 2015

News Daily News

After Pulmonary Embolism, Benefit of Secondary Anticoagulation Does Not Persist

L.A. McKeown

July 13, 2015

News Daily News

尽管未测得对生活质量有提升作用，但女性患者仍偏向于桡动脉入路的心导管术

Caitlin E. Cox

May 15, 2015

News Daily News

Despite No Measurable Gain in QoL, Women Still Prefer Radial for Cardiac Cath

Caitlin E. Cox

May 15, 2015

News Daily News

FDA Panel Backs Cangrelor for Use in PCI

Todd Neale

April 29, 2015

News Daily News

桡动脉与股动脉入路效果相当，在女性中尤其如此

Yael L. Maxwell

April 28, 2015

News Daily News

Substantial Minority of Low-Risk A-fib Patients Still Given Anticoagulants

Salynn Boyles

April 28, 2015

News Daily News

Radial RIVALs Femoral Access, Especially in Women

Yael L. Maxwell

April 28, 2015

News Daily News

El Abordaje Radial RIVALiza con el Femoral Sobre Todo en Mujeres

Yael L. Maxwell

April 28, 2015

News Daily News

Vorapaxar可对先前患过心梗的糖尿病患者起到有效的二级预防作用

L.A. McKeown

February 22, 2015

News Daily News

Vorapaxar es Eficaz como Prevención Secundaria en Pacientes Diabéticos con Antecedentes de IM

L.A. McKeown

February 22, 2015

News Daily News

Vorapaxar Effective for Secondary Prevention in Diabetic Patients With Prior MI

L.A. McKeown

February 22, 2015

Presentation

Vorapaxar in Patients with Diabetes and Prior MI:Findings from the TRA 2ºP-TIMI 50 Trial

Presenter: M.A. Cavender

February 19, 2015

News Daily News

Subestudio del HORIZONS-AMI: Las Mujeres Corren Más Riego Hemorrágico Post-STEMI

Yael L. Maxwell

October 03, 2014

News Daily News

HORIZONS-AMI亚组研究：妇女在STEMI后的出血风险更高

Yael L. Maxwell

October 03, 2014

News Daily News

HORIZONS-AMI Substudy: Women at Higher Risk for Bleeding After STEMI

Yael L. Maxwell

October 03, 2014

Advertisement

Transradial PCI May Attenuate Bivalirudin Benefits

BASKET-PROVE Substudy: DES Better Than BMS in Elderly Patients With Large Arteries

Navidea and Massachusetts General Hospital to Evaluate Manocept™ for Detection of Cardiovascular Disease with NIH Grant

肺栓塞发作后，二级抗凝效果未持续

Después de Sufrir un Embolismo Pulmonar el Beneficio de la Anticoagulación Secundaria No se Mantiene

After Pulmonary Embolism, Benefit of Secondary Anticoagulation Does Not Persist

尽管未测得对生活质量有提升作用，但女性患者仍偏向于桡动脉入路的心导管术

Despite No Measurable Gain in QoL, Women Still Prefer Radial for Cardiac Cath

FDA Panel Backs Cangrelor for Use in PCI

桡动脉与股动脉入路效果相当，在女性中尤其如此

Substantial Minority of Low-Risk A-fib Patients Still Given Anticoagulants

Radial RIVALs Femoral Access, Especially in Women

El Abordaje Radial RIVALiza con el Femoral Sobre Todo en Mujeres

Vorapaxar可对先前患过心梗的糖尿病患者起到有效的二级预防作用

Vorapaxar es Eficaz como Prevención Secundaria en Pacientes Diabéticos con Antecedentes de IM

Vorapaxar Effective for Secondary Prevention in Diabetic Patients With Prior MI

Vorapaxar in Patients with Diabetes and Prior MI:Findings from the TRA 2ºP-TIMI 50 Trial

Subestudio del HORIZONS-AMI: Las Mujeres Corren Más Riego Hemorrágico Post-STEMI

HORIZONS-AMI亚组研究：妇女在STEMI后的出血风险更高

HORIZONS-AMI Substudy: Women at Higher Risk for Bleeding After STEMI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content